Error: Could not add to watchlist. X

Geron Corp

+ Watchlist
GERN:US
NASDAQ GS
3.01
USD
0.08
2.73%
As of 09:32:30 ET on 09/02/2015.
Open
3.00
Day Range
3.00 - 3.05
Volume
47,343
Previous Close
2.93
52Wk Range
1.76 - 4.67
1 Yr Return
22.59%
Open
3.00
Day Range
3.00 - 3.05
Volume
47,343
Previous Close
2.93
52Wk Range
1.76 - 4.67
1 Yr Return
22.59%
YTD Return
-9.85%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.23
Market Cap (m USD)
463.357
Shares Outstanding (m)
158.142
Price/Sales (TTM)
409.83
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
ADDRESS
230 Consititution Drive
Menlo Park, CA 94025
United States
PHONE
1-650-473-7700
  • Huh Hoyoung
    Chairman
  • John A Scarlett
    President/CEO
  • Stephen N Rosenfield
    Exec VP/Secretary/General Counsel
  • Melissa A Kelly Behrs
    Exec VP:Business Development
  • Andrew J Grethlein "Andy"
    Exec VP:Dev & Tech Operations
Show More